01 1THINQ Pharma-CRO PVT Ltd
01 1OXYBUTYNIN CHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-12
Pay. Date : 2020-06-15
DMF Number : 34336
Submission : 2020-06-26
Status : Active
Type : II
20
Thinq Pharma-cro Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OXYBUTYNIN CHLORIDE USP, with a corresponding US DMF Number 34336.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 12, 2020, and payment made on June 15, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
